3-N-Butylphthalide
The risk or severity of adverse effects can be increased when Butylphthalide is combined with Olsalazine.
Abciximab
Olsalazine may increase the anticoagulant activities of Abciximab.
Acarbose
Olsalazine may increase the hypoglycemic activities of Acarbose.
Advertisement
Acebutolol
Olsalazine may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
Aceclofenac may increase the nephrotoxic activities of Olsalazine.
Acemetacin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Acemetacin.
Advertisement
Acenocoumarol
Olsalazine may increase the anticoagulant activities of Acenocoumarol.
Acetazolamide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Acetazolamide.
Acetyl salicylate
Acetylsalicylic acid may increase the nephrotoxic activities of Olsalazine.
Advertisement
Acetyldigitoxin
The serum concentration of Acetyldigitoxin can be decreased when it is combined with Olsalazine.
Aclarubicin
Olsalazine may decrease the excretion rate of Aclarubicin which could result in a higher serum level.
Adapalene
Adapalene may increase the nephrotoxic activities of Olsalazine.
Albiglutide
Olsalazine may increase the hypoglycemic activities of Albiglutide.
Alclometasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Alendronic acid.
Aliskiren
Olsalazine may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
Alminoprofen may increase the nephrotoxic activities of Olsalazine.
Alogliptin
Olsalazine may increase the hypoglycemic activities of Alogliptin.
Aloxiprin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Aloxiprin.
Alprenolol
Olsalazine may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Olsalazine.
Alteplase
The risk or severity of adverse effects can be increased when Olsalazine is combined with Alteplase.
Amcinonide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Amcinonide.
Amikacin
Olsalazine may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Olsalazine may decrease the antihypertensive activities of Amiloride.
Aminosalicylic Acid
Aminosalicylic Acid may increase the anticoagulant activities of Olsalazine.
Ammonium Chloride
The serum concentration of Olsalazine can be increased when it is combined with Ammonium chloride.
Anagrelide
The risk or severity of adverse effects can be increased when Anagrelide is combined with Olsalazine.
Ancrod
Olsalazine may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Olsalazine is combined with Androstenedione.
Anhydrous Tacrolimus
Olsalazine may increase the nephrotoxic activities of Tacrolimus.
Anistreplase
The risk or severity of adverse effects can be increased when Olsalazine is combined with Anistreplase.
Antipyrine
Antipyrine may increase the nephrotoxic activities of Olsalazine.
Antithrombin III
Olsalazine may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Olsalazine may increase the anticoagulant activities of Antithrombin III human.
Apazone
Azapropazone may increase the nephrotoxic activities of Olsalazine.
Apixaban
Olsalazine may increase the anticoagulant activities of Apixaban.
Apremilast
Apremilast may increase the nephrotoxic activities of Olsalazine.
Arbekacin
Olsalazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Olsalazine may increase the anticoagulant activities of Ardeparin.
Argatroban
Olsalazine may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Olsalazine may increase the anticoagulant activities of Argatroban.
Aspirin
Acetylsalicylic acid may increase the nephrotoxic activities of Olsalazine.
Astaxanthin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Astaxanthin.
Atenolol
Olsalazine may decrease the antihypertensive activities of Atenolol.
Azathioprine
The metabolism of Azathioprine can be decreased when combined with Olsalazine.
Azelastine
Azelastine may increase the nephrotoxic activities of Olsalazine.
azficel-T
The risk or severity of adverse effects can be increased when Olsalazine is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Olsalazine.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Olsalazine.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Olsalazine.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Olsalazine.
Balsalazide
Balsalazide may increase the nephrotoxic activities of Olsalazine.
Becaplermin
Olsalazine may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Beclomethasone dipropionate.
Bemiparin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Bemiparin.
Benazepril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Olsalazine.
Benzydamine
Benzydamine may increase the nephrotoxic activities of Olsalazine.
Betamethasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Betamethasone.
Betaxolol
Olsalazine may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Olsalazine.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Olsalazine.
Bisoprolol
Olsalazine may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Olsalazine may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Olsalazine may decrease the antihypertensive activities of Bopindolol.
Brinzolamide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Brinzolamide.
Bromfenac
Bromfenac may increase the nephrotoxic activities of Olsalazine.
Bromocriptine
Olsalazine may increase the hypoglycemic activities of Bromocriptine.
Budesonide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Budesonide.
Bufexamac
Bufexamac may increase the nephrotoxic activities of Olsalazine.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Olsalazine.
Bupranolol
Olsalazine may decrease the antihypertensive activities of Bupranolol.
Canagliflozin
Olsalazine may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Olsalazine may increase the hypoglycemic activities of Canagliflozin.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Olsalazine.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Olsalazine.
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Olsalazine.
Captopril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Captopril.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Olsalazine.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Olsalazine.
Carprofen
Carprofen may increase the nephrotoxic activities of Olsalazine.
Carteolol
Olsalazine may decrease the antihypertensive activities of Carteolol.
Carvedilol
Olsalazine may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Olsalazine is combined with Celecoxib.
Celiprolol
Olsalazine may decrease the antihypertensive activities of Celiprolol.
Certoparin
Olsalazine may increase the anticoagulant activities of Certoparin.
Chloroquine
Chloroquine may increase the nephrotoxic activities of Olsalazine.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Olsalazine.
Chlorpropamide
Olsalazine may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Olsalazine.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Olsalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may increase the nephrotoxic activities of Olsalazine.
Ciclesonide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Cilazapril.
Cilostazol
The risk or severity of adverse effects can be increased when Cilostazol is combined with Olsalazine.
Cinoxacin
Olsalazine may increase the neuroexcitatory activities of Cinoxacin.
Citric Acid
Olsalazine may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Olsalazine may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Olsalazine is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Clodronic Acid.
Clonixin
Clonixin may increase the nephrotoxic activities of Olsalazine.
Clopidogrel
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Olsalazine.
Colesevelam
Colesevelam can cause a decrease in the absorption of Olsalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Olsalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Cortisone acetate.
Curcumin
Curcumin may increase the nephrotoxic activities of Olsalazine.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Olsalazine.
Cyclosporine
Olsalazine may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Olsalazine may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Olsalazine may increase the anticoagulant activities of Dalteparin.
Danaparoid
Olsalazine may increase the anticoagulant activities of Danaparoid.
Dapagliflozin
Olsalazine may increase the hypoglycemic activities of Dapagliflozin.
Daunorubicin
Olsalazine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Deferasirox
The risk or severity of adverse effects can be increased when Olsalazine is combined with Deferasirox.
Defibrotide
The risk or severity of adverse effects can be increased when Defibrotide is combined with Olsalazine.
Deflazacort
The risk or severity of adverse effects can be increased when Olsalazine is combined with Deflazacort.
Desirudin
Olsalazine may increase the anticoagulant activities of Desirudin.
Deslanoside
The serum concentration of Deslanoside can be decreased when it is combined with Olsalazine.
Desmopressin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Desoxycorticosterone Pivalate.
Dexamethasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Olsalazine.
Dextran
Olsalazine may increase the anticoagulant activities of Dextran.
Dextran 40
Olsalazine may increase the anticoagulant activities of Dextran 40.
Dextran 70
Olsalazine may increase the anticoagulant activities of Dextran 70.
Dextran 75
Olsalazine may increase the anticoagulant activities of Dextran 75.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Diclofenamide.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Olsalazine.
Dicumarol
Olsalazine may increase the anticoagulant activities of Dicoumarol.
Diflorasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Difluocortolone.
Diflunisal
Diflunisal may increase the nephrotoxic activities of Olsalazine.
Difluprednate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Difluprednate.
Digitoxin
The serum concentration of Digitoxin can be decreased when it is combined with Olsalazine.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Olsalazine.
Dihydrostreptomycin
Olsalazine may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Diltiazem
Diltiazem may increase the anticoagulant activities of Olsalazine.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Olsalazine.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Olsalazine.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Olsalazine.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Olsalazine.
Dipyrone
Metamizole may increase the nephrotoxic activities of Olsalazine.
Disopyramide
Olsalazine may increase the hypoglycemic activities of Disopyramide.
Dorzolamide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Dorzolamide.
Doxorubicin
Olsalazine may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxorubicin Hydrochloride
Olsalazine may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Drospirenone
Olsalazine may increase the hyperkalemic activities of Drospirenone.
Drotrecogin Alfa
The risk or severity of adverse effects can be increased when Olsalazine is combined with Drotrecogin alfa.
Droxicam
Droxicam may increase the nephrotoxic activities of Olsalazine.
Dulaglutide
Olsalazine may increase the hypoglycemic activities of Dulaglutide.
Edetic Acid
Olsalazine may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Olsalazine may increase the anticoagulant activities of Edoxaban.
Empagliflozin
Olsalazine may increase the hypoglycemic activities of Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Olsalazine is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Olsalazine is combined with Enalaprilat.
Enoxacin
Olsalazine may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Olsalazine may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Olsalazine may increase the anticoagulant activities of Enoxaparin.
Epinastine
The risk or severity of adverse effects can be increased when Epinastine is combined with Olsalazine.
Epirubicin
Olsalazine may decrease the excretion rate of Epirubicin which could result in a higher serum level.
Eplerenone
Olsalazine may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Olsalazine.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Olsalazine.
Eptifibatide
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Olsalazine.
Esmolol
Olsalazine may decrease the antihypertensive activities of Esmolol.
Estrone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Estrone.
Etanercept
Etanercept may increase the nephrotoxic activities of Olsalazine.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Olsalazine.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Olsalazine.
Ethylenediaminetetraacetate
Olsalazine may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Olsalazine is combined with Etodolac.
Etofenamate
Etofenamate may increase the nephrotoxic activities of Olsalazine.
Etoricoxib
The risk or severity of adverse effects can be increased when Olsalazine is combined with Etoricoxib.
Evening primrose oil
Evening primrose oil may increase the nephrotoxic activities of Olsalazine.
Exenatide
Olsalazine may increase the hypoglycemic activities of Exenatide.
Felbinac
Felbinac may increase the nephrotoxic activities of Olsalazine.
Fenbufen
Fenbufen may increase the nephrotoxic activities of Olsalazine.
Fenoprofen
Fenoprofen may increase the nephrotoxic activities of Olsalazine.
Ferulic Acid
Ferulic acid may increase the nephrotoxic activities of Olsalazine.
Fleroxacin
Olsalazine may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Olsalazine.
Fludrocortisone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fludrocortisone.
Fluindione
Olsalazine may increase the anticoagulant activities of Fluindione.
Flumequine
Olsalazine may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Olsalazine is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluorometholone.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Flurandrenolide.
Flurbiprofen
Flurbiprofen may increase the nephrotoxic activities of Olsalazine.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluticasone propionate.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Olsalazine.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Olsalazine.
Fondaparinux
Olsalazine may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Olsalazine may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Olsalazine is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fosinopril.
Framycetin
Olsalazine may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Olsalazine.
Gatifloxacin
Olsalazine may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Olsalazine may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Olsalazine.
Gemifloxacin
Olsalazine may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Olsalazine may increase the neuroexcitatory activities of Gemifloxacin.
Gentamicin
Olsalazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Ginkgo biloba extract
Ginkgo biloba may increase the anticoagulant activities of Olsalazine.
Gliclazide
Olsalazine may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Olsalazine may increase the hypoglycemic activities of Glimepiride.
Glipizide
Olsalazine may increase the hypoglycemic activities of Glipizide.
Glyburide
Olsalazine may increase the hypoglycemic activities of Glyburide.
Grepafloxacin
Olsalazine may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Olsalazine is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Olsalazine is combined with Haloperidol.
Heparin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Heparin.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Olsalazine.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Olsalazine.
Hydralazine
Olsalazine may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Olsalazine.
Hydrocortisone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Olsalazine.
Hydroxytyrosol
The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Olsalazine.
Ibandronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Ibandronate.
Ibuprofen
Ibuprofen may increase the nephrotoxic activities of Olsalazine.
Icatibant
Icatibant may increase the nephrotoxic activities of Olsalazine.
Icosapent Ethyl
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Olsalazine.
Idarubicin
Olsalazine may decrease the excretion rate of Idarubicin which could result in a higher serum level.
Ifenprodil
The risk or severity of adverse effects can be increased when Ifenprodil is combined with Olsalazine.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Olsalazine.
Imidapril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Olsalazine.
Indobufen
The risk or severity of adverse effects can be increased when Olsalazine is combined with Indobufen.
Indomethacin
Indomethacin may increase the nephrotoxic activities of Olsalazine.
Insulin Detemir
Olsalazine may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Olsalazine may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Olsalazine may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Olsalazine may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Olsalazine may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Olsalazine may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Olsalazine may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Olsalazine may increase the hypoglycemic activities of Insulin Lispro.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Olsalazine.
Kanamycin
Olsalazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Olsalazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
Kebuzone may increase the nephrotoxic activities of Olsalazine.
Ketanserin
The risk or severity of adverse effects can be increased when Ketanserin is combined with Olsalazine.
Ketoprofen
Ketoprofen may increase the nephrotoxic activities of Olsalazine.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Olsalazine.
Labetalol
Olsalazine may decrease the antihypertensive activities of Labetalol.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Olsalazine.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Olsalazine.
Leflunomide
Leflunomide may increase the nephrotoxic activities of Olsalazine.
Lepirudin
Olsalazine may increase the anticoagulant activities of Lepirudin.
Levobunolol
Olsalazine may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Olsalazine may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Olsalazine may increase the neuroexcitatory activities of Levofloxacin.
Limonene, (+)-
(4R)-limonene may increase the nephrotoxic activities of Olsalazine.
Liraglutide
Olsalazine may increase the hypoglycemic activities of Liraglutide.
Lisinopril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Olsalazine is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Olsalazine.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Olsalazine.
Lornoxicam
Lornoxicam may increase the nephrotoxic activities of Olsalazine.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Olsalazine.
Loteprednol
The risk or severity of adverse effects can be increased when Olsalazine is combined with Loteprednol.
Loxoprofen
Loxoprofen may increase the nephrotoxic activities of Olsalazine.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Olsalazine.
Magnesium Salicylate
Magnesium salicylate may increase the nephrotoxic activities of Olsalazine.
Masoprocol
Masoprocol may increase the nephrotoxic activities of Olsalazine.
Mecasermin
Olsalazine may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Olsalazine may increase the hypoglycemic activities of Mecasermin.
Meclofenamate
Meclofenamic acid may increase the nephrotoxic activities of Olsalazine.
Meclofenamic Acid
Meclofenamic acid may increase the nephrotoxic activities of Olsalazine.
Medronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Medrysone.
Mefenamic Acid
Mefenamic acid may increase the nephrotoxic activities of Olsalazine.
Meloxicam
Meloxicam may increase the nephrotoxic activities of Olsalazine.
Mercaptopurine
The metabolism of Mercaptopurine can be decreased when combined with Olsalazine.
MERCAPTOPURINE ANHYDROUS
The metabolism of Mercaptopurine can be decreased when combined with Olsalazine.
Mesalamine
Mesalazine may increase the nephrotoxic activities of Olsalazine.
Metformin
Olsalazine may increase the hypoglycemic activities of Metformin.
Methazolamide
The risk or severity of adverse effects can be increased when Olsalazine is combined with Methazolamide.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Olsalazine.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Olsalazine.
Methyl Salicylate
Olsalazine may increase the anticoagulant activities of Methyl salicylate.
Methylprednisolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Methylprednisolone.
Metipranolol
Olsalazine may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Olsalazine.
Metoprolol
Olsalazine may decrease the antihypertensive activities of Metoprolol.
Metrizamide
Olsalazine may decrease the excretion rate of Metrizamide which could result in a higher serum level.
Mifepristone
Olsalazine may increase the hypoglycemic activities of Mifepristone.
Miglitol
Olsalazine may increase the hypoglycemic activities of Miglitol.
Milrinone
The risk or severity of adverse effects can be increased when Milrinone is combined with Olsalazine.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Olsalazine.
Moexipril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Olsalazine.
MYCOPHENOLATE
Mycophenolic acid may increase the nephrotoxic activities of Olsalazine.
Mycophenolate Mofetil
Mycophenolate mofetil may increase the nephrotoxic activities of Olsalazine.
Mycophenolic Acid
Mycophenolic acid may increase the nephrotoxic activities of Olsalazine.
Nabumetone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Nabumetone.
Nadolol
Olsalazine may decrease the antihypertensive activities of Nadolol.
Nadroparin
Olsalazine may increase the anticoagulant activities of Nadroparin.
Naftifine
Naftifine may increase the nephrotoxic activities of Olsalazine.
Nalidixic Acid
Olsalazine may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
Naproxen may increase the nephrotoxic activities of Olsalazine.
Nateglinide
Olsalazine may increase the hypoglycemic activities of Nateglinide.
Nebivolol
Olsalazine may decrease the antihypertensive activities of Nebivolol.
Neomycin
Olsalazine may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
Nepafenac may increase the nephrotoxic activities of Olsalazine.
Netilmicin
Olsalazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Niflumic Acid
Niflumic Acid may increase the nephrotoxic activities of Olsalazine.
Nimesulide
Nimesulide may increase the nephrotoxic activities of Olsalazine.
Norfloxacin
Olsalazine may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
Evening primrose oil may increase the nephrotoxic activities of Olsalazine.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Olsalazine.
Olopatadine
Olopatadine may increase the nephrotoxic activities of Olsalazine.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Olsalazine is combined with Omacetaxine mepesuccinate.
Ouabain
The serum concentration of Ouabain can be decreased when it is combined with Olsalazine.
Ovine Digoxin Immune Fab
The serum concentration of Digoxin Immune Fab (Ovine) can be decreased when it is combined with Olsalazine.
Oxaprozin
Oxaprozin may increase the nephrotoxic activities of Olsalazine.
Oxprenolol
Olsalazine may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
Oxyphenbutazone may increase the nephrotoxic activities of Olsalazine.
Pamidronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Olsalazine is combined with Parecoxib.
Parnaparin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Parnaparin.
Paromomycin
Olsalazine may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Parthenolide
Parthenolide may increase the nephrotoxic activities of Olsalazine.
Pefloxacin
Olsalazine may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Olsalazine may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Olsalazine may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentamidine
Olsalazine may increase the hypoglycemic activities of Pentamidine.
Pentosan Polysulfate
Olsalazine may increase the anticoagulant activities of Pentosan Polysulfate.
Pentoxifylline
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Olsalazine.
Perindopril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Perindopril.
Phenindione
Olsalazine may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Olsalazine may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
Phenylbutazone may increase the nephrotoxic activities of Olsalazine.
Pimecrolimus
Pimecrolimus may increase the nephrotoxic activities of Olsalazine.
Pindolol
Olsalazine may decrease the antihypertensive activities of Pindolol.
Pioglitazone
Olsalazine may increase the hypoglycemic activities of Pioglitazone.
Pirarubicin
Olsalazine may decrease the excretion rate of Pirarubicin which could result in a higher serum level.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Olsalazine.
Pirfenidone
Pirfenidone may increase the nephrotoxic activities of Olsalazine.
Piroxicam
Piroxicam may increase the nephrotoxic activities of Olsalazine.
Piroxicam-Beta-Cyclodextrin
Piroxicam may increase the nephrotoxic activities of Olsalazine.
Plasmin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fibrinolysin.
Plicamycin
Olsalazine may decrease the excretion rate of Plicamycin which could result in a higher serum level.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Olsalazine.
Practolol
Olsalazine may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Olsalazine.
Pramlintide
Olsalazine may increase the hypoglycemic activities of Pramlintide.
Prasterone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Prasterone.
Prasugrel
The risk or severity of adverse effects can be increased when Prasugrel is combined with Olsalazine.
Prednicarbate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Pregnenolone.
Probenecid
The serum concentration of Olsalazine can be increased when it is combined with Probenecid.
Propranolol
Olsalazine may decrease the antihypertensive activities of Propranolol.
Proscillaridin
The serum concentration of Proscillaridin can be decreased when it is combined with Olsalazine.
protein C, human
Olsalazine may increase the anticoagulant activities of Protein C.
protein S, human
Olsalazine may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Olsalazine may increase the anticoagulant activities of Protocatechualdehyde.
Quinapril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Quinapril.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Olsalazine.
Quinine
Olsalazine may increase the hypoglycemic activities of Quinine.
Ramipril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Ramipril.
Regular Insulin, Human
Olsalazine may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Olsalazine may increase the hypoglycemic activities of Repaglinide.
Rescinnamine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Rescinnamine.
Resveratrol
Resveratrol may increase the nephrotoxic activities of Olsalazine.
Reteplase
The risk or severity of adverse effects can be increased when Olsalazine is combined with Reteplase.
Reviparin
Olsalazine may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Olsalazine may increase the anticoagulant activities of Reviparin.
Rimexolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Risedronate.
Rivaroxaban
Olsalazine may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Olsalazine is combined with Rofecoxib.
Rosiglitazone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Rosiglitazone.
Rosoxacin
Olsalazine may increase the neuroexcitatory activities of Rosoxacin.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Olsalazine.
Salicylamide
Salicylamide may increase the nephrotoxic activities of Olsalazine.
Salicylic Acid
Salicylic acid may increase the nephrotoxic activities of Olsalazine.
Salsalate
Salsalate may increase the nephrotoxic activities of Olsalazine.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Olsalazine.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Olsalazine.
Saxagliptin
Olsalazine may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Olsalazine may increase the hypoglycemic activities of Saxagliptin.
Selexipag
The risk or severity of adverse effects can be increased when Olsalazine is combined with Selexipag.
Serratiopeptidase
Serrapeptase may increase the nephrotoxic activities of Olsalazine.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Olsalazine.
Sisomicin
Olsalazine may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sitagliptin
Olsalazine may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Olsalazine may increase the hypoglycemic activities of Sitagliptin.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Olsalazine.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Olsalazine.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Olsalazine.
Sotalol
Olsalazine may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Olsalazine may increase the neuroexcitatory activities of Sparfloxacin.
Spectinomycin
Olsalazine may decrease the excretion rate of Spectinomycin which could result in a higher serum level.
Spirapril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Spirapril.
Spironolactone
Olsalazine may decrease the antihypertensive activities of Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Olsalazine is combined with Streptokinase.
Streptomycin
Olsalazine may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Streptozocin
Olsalazine may decrease the excretion rate of Streptozocin which could result in a higher serum level.
Sulfadiazine
Olsalazine may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Olsalazine may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfasalazine
Sulfasalazine may increase the nephrotoxic activities of Olsalazine.
Sulfisoxazole
Olsalazine may increase the hypoglycemic activities of Sulfisoxazole.
Sulindac
Sulindac may increase the nephrotoxic activities of Olsalazine.
Sunitinib
Olsalazine may increase the hypoglycemic activities of Sunitinib.
Suprofen
Suprofen may increase the nephrotoxic activities of Olsalazine.
Tacrolimus
Olsalazine may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Olsalazine.
Talinolol
Olsalazine may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Olsalazine.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Olsalazine.
Temafloxacin
Olsalazine may increase the neuroexcitatory activities of Temafloxacin.
Tenecteplase
The risk or severity of adverse effects can be increased when Olsalazine is combined with Tenecteplase.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Olsalazine is combined with Tenofovir disoproxil.
Tenoxicam
Tenoxicam may increase the nephrotoxic activities of Olsalazine.
Teriflunomide
Teriflunomide may increase the nephrotoxic activities of Olsalazine.
Thioguanine
The metabolism of Tioguanine can be decreased when combined with Olsalazine.
Tiaprofenic Acid
Tiaprofenic acid may increase the nephrotoxic activities of Olsalazine.
Ticagrelor
The risk or severity of adverse effects can be increased when Olsalazine is combined with Ticagrelor.
Ticlopidine
The risk or severity of adverse effects can be increased when Ticlopidine is combined with Olsalazine.
Tiludronate
The risk or severity of adverse effects can be increased when Olsalazine is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Tiludronic acid.
Timolol
Olsalazine may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Olsalazine may decrease the antihypertensive activities of Timolol.
Tinzaparin
The risk or severity of adverse effects can be increased when Olsalazine is combined with Tinzaparin.
Tinzaparin sodium
The risk or severity of adverse effects can be increased when Olsalazine is combined with Tinzaparin.
Tirofiban
The risk or severity of adverse effects can be increased when Tirofiban is combined with Olsalazine.
Tixocortol
The risk or severity of adverse effects can be increased when Olsalazine is combined with Tixocortol.
Tobramycin
Olsalazine may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolazamide
Olsalazine may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Olsalazine may increase the hypoglycemic activities of Tolbutamide.
Tolfenamic Acid
Tolfenamic Acid may increase the nephrotoxic activities of Olsalazine.
Tolmetin
Tolmetin may increase the nephrotoxic activities of Olsalazine.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Olsalazine.
Trandolapril
The risk or severity of adverse effects can be increased when Olsalazine is combined with Trandolapril.
Tranilast
Tranilast may increase the nephrotoxic activities of Olsalazine.
Trapidil
The risk or severity of adverse effects can be increased when Trapidil is combined with Olsalazine.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Olsalazine.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Olsalazine.
Triamcinolone
The risk or severity of adverse effects can be increased when Olsalazine is combined with Triamcinolone.
Triamterene
Olsalazine may decrease the antihypertensive activities of Triamterene.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Olsalazine.
Triflusal
The risk or severity of adverse effects can be increased when Triflusal is combined with Olsalazine.
Trolamine Salicylate
Olsalazine may increase the anticoagulant activities of Trolamine salicylate.
Trovafloxacin
Olsalazine may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Olsalazine may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Olsalazine.
Urokinase
The risk or severity of adverse effects can be increased when Olsalazine is combined with Urokinase.
Valdecoxib
The risk or severity of adverse effects can be increased when Olsalazine is combined with Valdecoxib.
Valproate
The serum concentration of Valproic Acid can be increased when it is combined with Olsalazine.
Valproic Acid
The serum concentration of Valproic Acid can be increased when it is combined with Olsalazine.
Valrubicin
Olsalazine may decrease the excretion rate of Valrubicin which could result in a higher serum level.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Olsalazine.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Olsalazine.
Verapamil
Verapamil may increase the anticoagulant activities of Olsalazine.
Vorapaxar
The risk or severity of adverse effects can be increased when Vorapaxar is combined with Olsalazine.
Warfarin
Olsalazine may increase the anticoagulant activities of Warfarin.
Zileuton
Zileuton may increase the nephrotoxic activities of Olsalazine.
Zofenopril
The therapeutic efficacy of Zofenopril can be decreased when used in combination with Olsalazine.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Olsalazine is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Olsalazine is combined with Zoledronic acid.
Zomepirac
Zomepirac may increase the nephrotoxic activities of Olsalazine.
